Coptisine alleviates ischemia/reperfusion-induced myocardial damage by regulating apoptosis-related proteins

Tissue Cell. 2020 Oct:66:101392. doi: 10.1016/j.tice.2020.101392. Epub 2020 Jun 1.

Abstract

Coptisine is an alkaloid with many biological functions, but studies on its mechanism in myocardial ischemia-reperfusion (I/R) injury are less reported. Hypoxia-reoxygenation (H/R) -treated cardiomyocytes injury and I/R-induced myocardial tissues damage were created in rat models with or without the pre-treatment of coptisine. The proliferation and apoptosis of cardiomyocytes and changes of myocardial tissues were observed after the pre-treatment of coptisine. The pre-treatment of coptisine promoted cell proliferation and inhibited apoptosis of H/R-injured cardiomyocytes, and alleviated the myocardial tissue injury caused by I/R in rats. Moreover, coptisine promoted the expressions of anti-apoptotic proteins and inhibited the expressions of pro-apoptotic proteins in vivo and in vitro. The current study found that coptisine had protective effects on I/R-induced myocardial damage, which may provide a new insight into the treatment of I/R.

Keywords: Apoptosis; Coptisine; Ischemia-reperfusion; Viability; hypoxia–reoxygenation.

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins / metabolism*
  • Berberine / analogs & derivatives*
  • Berberine / pharmacology
  • Cell Hypoxia / drug effects
  • Cell Proliferation / drug effects
  • Male
  • Myocardial Reperfusion Injury / pathology*
  • Myocardium / pathology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Oxygen
  • Rats, Sprague-Dawley

Substances

  • Apoptosis Regulatory Proteins
  • coptisine
  • Berberine
  • Oxygen